Prevalence of Oral Disorders in Children in ENT Pathologies

NCT ID: NCT05909787

Last Updated: 2023-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

2000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-01

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many children have eating and verbal oral disorders. Our research entitled: PREORA aims to study the prevalence of oral disorders presented in children consulting in ENT department for three months (n = 2000). This first study will be carried out by passing the MCH (Montreal Children's Hospital) feeding scale, a self-questionnaire completed by the parents, in order to assess the presence of disorders according to the parents and will allow us to present oral disorders (Score \> 70).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over a period of inclusion of 3 months, the doctors of the departement ONT, Robert Debré Hospital, will give written and oral information to the holders of parental authority and to the child at the beginning of the consultation. After a 15-minute reflection period (consultation time), if they agree to participate, parents will answer the doctor's questions and then complete the self-questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eating Disorders Language Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Auto-questionnaire MCH (Montreal Children's Hospital)

Auto-questionnaire MCH (Montreal Children's Hospital)

Group Type EXPERIMENTAL

Auto-questionnaire

Intervention Type OTHER

MCH (Montreal Children's Hospital) self questionnaire completed by the parents

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Auto-questionnaire

MCH (Montreal Children's Hospital) self questionnaire completed by the parents

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients consulting at ENT departement Robert Debré Hospital
* Age 0-17 years
* Parents and children informed and given their oral consent for the study and speaking french

Exclusion Criteria

* Refusal of parents/children to participate
Minimum Eligible Age

1 Day

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natacha TEISSIER, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natacha TEISSIER, PhD

Role: CONTACT

+331 40 03 53 67

Elise CHAUVIN, PhD student

Role: CONTACT

+331 87 46 82 21

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IDRCB: 2023-A00201-44

Identifier Type: REGISTRY

Identifier Source: secondary_id

APHP230191

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Eating Disorders Among Adolescents
NCT05722470 NOT_YET_RECRUITING